Oligodendrocyte‐Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer's Disease via Modulation of HDAC2 Phosphorylation
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71150 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 08.09.2026. Verfasst von Shiji Deng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China. Hauptthemen laut MEDLINE: Immediate-Early Proteins, Histone Deacetylase 2, Alzheimer Disease, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, STI2030-Major Projects, Jiangsu Province Key Medical Discipline.
Themen: Demenz
Abstract (Originalsprache)
Background
White matter (WM) abnormalities contribute to cognitive decline in Alzheimer's disease (AD). However, the mechanisms underlying AD‐associated WM vulnerability remain incompletely understood, and effective therapeutic strategies to improve WM pathology are still limited.
Methods
Sgk1.1 ‐specific RNAscope combined with Olig2 immunostaining was used to assess the cellular distribution of Sgk1.1 transcripts. Oligodendrocyte‐targeted adeno‐associated virus (AAV)‐mediated Sgk1.1 knockdown was performed in 5 × FAD mice. Sgk1.1 overexpression was conducted in primary oligodendrocyte precursor cells (OPCs) in vitro. Phosphoproteomic profiling, co‐immunoprecipitation, Phos‐tag Western blot, and phospho‐site mutagenesis were used to identify downstream mechanisms. A bilateral common carotid artery stenosis (BCAS) model was employed to assess broader relevance.
Results
Sgk1.1 mRNA was predominantly elevated in oligodendrocyte‐lineage cells of 5 × FAD mice prior to overt myelin loss. Targeted knockdown of oligodendroglial Sgk1.1 ameliorated cognitive deficits, preserved myelin ultrastructure, and promoted oligodendrocyte maturation. Conversely, Sgk1.1 overexpression arrested OPC differentiation and suppressed myelin gene expression in vitro. Mechanistically, SGK1.1 promoted HDAC2 phosphorylation at S422/S424, and blocking this phosphorylation partially reversed SGK1.1‐induced maturation deficits. Furthermore, oligodendrocyte‐targeted Sgk1.1 overexpression exacerbated WM injury and cognitive impairment in the BCAS model.
Conclusion
Our findings identify oligodendrocyte‐targeted SGK1.1 inhibition as a tractable therapeutic strategy to preserve WM integrity and cognitive function, and define HDAC2 S422/S424 phosphorylation as a mechanistic node linking SGK1.1 signaling to impaired myelination in AD and related demyelinating disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China.
- The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, China.
- Department of Neurology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.
- MOE Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing, China.
- State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China.
- Jiangsu Key Laboratory for Molecular Medicine, Medical School, Nanjing University, Nanjing, China.
ORCID-Profile: Chao Zhou, Zhen Lan, Jiang Chen, Yuhao Xu, Xinyu Bao, Tingting Wang, Yun Xu, Xiaolei Zhu
Förderung
- National Natural Science Foundation of China
- STI2030-Major Projects
- Jiangsu Province Key Medical Discipline
Zitieren
APA
Deng, S., Gao, S., Zhou, C., Lan, Z., Li, H., Chen, J., Xu, Y., Li, J., Liu, P., Zhang, S., Bao, X., Wang, T., Xu, Y., & Zhu, X. (2026). Oligodendrocyte‐Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer's Disease via Modulation of HDAC2 Phosphorylation. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71150
Vancouver
Deng S, Gao S, Zhou C, Lan Z, Li H, Chen J, et al. Oligodendrocyte‐Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer's Disease via Modulation of HDAC2 Phosphorylation. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71150
BibTeX
@article{Deng2026,
author = {Deng, Shiji and Gao, Shenghan and Zhou, Chao and Lan, Zhen and Li, Huiya and Chen, Jiang and Xu, Yuhao and Li, Jiashuo and Liu, Pinyi and Zhang, Siyuan and Bao, Xinyu and Wang, Tingting and Xu, Yun and Zhu, Xiaolei},
title = {Oligodendrocyte‐Targeted SGK1.1 Inhibition Alleviates White Matter Injury and Cognitive Impairment in Alzheimer's Disease via Modulation of HDAC2 Phosphorylation},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71150}
}
EUVIMED